In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
Building a digital therapeutic for paediatric behavioural health opioids
Gene silencing and mRNA: breakthroughs and barriers
Rethinking pharmaceutical pain management beyond opioids
Why diverse clinical trials matter
Where pharma stands on patient centricity, engagement, and trust
How pharma can spur innovation and promote health equity in mental health
Innovative solutions to the drug pricing crisis: the pharmaphorum podcast
Big data and how it can change the game in pharma: the pharmaphorum podcast
The year ahead in digital health and life sciences: the pharmaphorum podcast
The evolution of clinical trials: the pharmaphorum podcast
Patient engagement processes: the pharmaphorum podcast
Real-world evidence and qualitative research: the ELICIT podcast
Merck on trends in oncology: the pharmaphorum podcast
Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast
Patient engagement strategies: the pharmaphorum podcast
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast
Virtual engagement and collaborations: the pharmaphorum podcast
Biotech Insight podcast: Overcoming planning challenges in oncology
Vertex senior country manager Nicola Massey: the pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology